Runx2 Deficiency in Osteoblasts Promotes Myeloma Resistance to Bortezomib by Increasing TSP-1-Dependent TGF{beta}1 Activation and Suppressing Immunity in Bone Marrow

Runx2 Deficiency in Osteoblasts Promotes Myeloma Resistance to Bortezomib by Increasing TSP-1–Dependent TGFβ1 Activation and Suppressing Immunity in Bone Marrow

Chao Zhang, Xiaoxuan Xu, Timothy N. Trotter, Pramod S. Gowda, Yun Lu, Mark J. Suto, Amjad Javed, Joanne E. Murphy-Ullrich, Juan Li and Yang Yang

Mol Cancer Ther February 1 2022 (21) (2) 347-358; DOI: 10.1158/1535-7163.MCT-21-0310

Comments (0)

No login
gif